Moderna Edges Pfizer in Study of Five Covid Vaccines

Bloomberg2021-11-26

TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Universe宇宙
2021-11-26
Universe宇宙
Does this article mean that Moderna have more side effects than the rest?
- Universe宇宙:
  buy more covid stocks to huat big big?
- Universe宇宙:
  why there is no cancer vaccine?
- Universe宇宙:
  why there is no hiv vaccine?
- Universe宇宙:
  rather than saying which covid vaccine is better, why not focus on which covid vaccine can totally remove the covid virus once and for all.
- Universe宇宙:
  maybe when more people take $Merck(MRK)$ covid pill, we will see an article title 'Moderna Edges Merck in Study of Covid Medicine'?
Rachlim
2021-11-26
Rachlim
Should buy?
- PrimRose:
  Go for it
S土豪熊貓G
2021-11-26
S土豪熊貓G
Yes, go for Modena. Buy and hodl for long!
MHh
2021-11-26
MHh
For completeness, would also want the side effects and their severity reported. Possible to have the best of both worlds with any of these 5?
- MHh回复Universe宇宙:
  [Happy]
- Universe宇宙回复MHh:
  How I wonder if the smallpox vaccine creator can be still alive, maybe he will be able to create a 1 jab covid vaccine that will make us immune from covid virus and also without side effects too.
- MHh回复Universe宇宙:
  Seems so, with varying efficacy
- MHh回复Universe宇宙:
  [Sick]
- MHh:
  Yes, that is the trade off. Hard to find a vaccine that is both efficacious and with not so serious side effects. Maybe novovax might fit the bill but not as widely used to tell
Terc
2021-11-26
Terc
Ok
- Terc:
  ok
Sphere
2021-11-26
Sphere
MRNA is more superior
- Sphere:
  Up

发表看法

104

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1178079040?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-26 07:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178079040","market":"us","top_or_hot":-1,"title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","media":"Bloomberg","content":"<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","article_id":"1178079040","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","pubTimestamp":1637883095,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"莫德纳在五种Covid疫苗的研究中领先辉瑞","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":877350715,"gmtCreate":1637890739253,"gmtModify":1637892302443,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Does this article mean that Moderna have more side effects than the rest?","listText":"Does this article mean that Moderna have more side effects than the rest?","text":"Does this article mean that Moderna have more side effects than the rest?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":15,"repostSize":0,"link":"https://laohu8.com/post/877350715","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6728411,"gmtCreate":1637893087935,"gmtModify":1637894287712,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877350715,"type":1,"supId":0,"prevId":0,"content":"buy more covid stocks to huat big big?","text":"buy more covid stocks to huat big big?","html":"buy more covid stocks to huat big big?"},{"id":6728227,"gmtCreate":1637892302394,"gmtModify":1637892302418,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877350715,"type":1,"supId":0,"prevId":0,"content":"why there is no cancer vaccine?","text":"why there is no cancer vaccine?","html":"why there is no cancer vaccine?"},{"id":6728220,"gmtCreate":1637892287212,"gmtModify":1637892287237,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877350715,"type":1,"supId":0,"prevId":0,"content":"why there is no hiv vaccine?","text":"why there is no hiv vaccine?","html":"why there is no hiv vaccine?"},{"id":6728100,"gmtCreate":1637891812808,"gmtModify":1637891812835,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877350715,"type":1,"supId":0,"prevId":0,"content":"rather than saying which covid vaccine is better, why not focus on which covid vaccine can totally remove the covid virus once and for all.","text":"rather than saying which covid vaccine is better, why not focus on which covid vaccine can totally remove the covid virus once and for all.","html":"rather than saying which covid vaccine is better, why not focus on which covid vaccine can totally remove the covid virus once and for all."},{"id":6728071,"gmtCreate":1637891723364,"gmtModify":1637891723451,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877350715,"type":1,"supId":0,"prevId":0,"content":"maybe when more people take <a href=\"https://laohu8.com/S/MRK\"> $Merck(MRK)$</a> covid pill, we will see an article title 'Moderna Edges Merck in Study of Covid Medicine'?","text":"maybe when more people take <a href=\"https://laohu8.com/S/MRK\"> $Merck(MRK)$</a> covid pill, we will see an article title 'Moderna Edges Merck in Study of Covid Medicine'?","html":"maybe when more people take <a href=\"https://laohu8.com/S/MRK\"> $Merck(MRK)$</a> covid pill, we will see an article title 'Moderna Edges Merck in Study of Covid Medicine'?"}],"langContent":"CN"},{"id":877393648,"gmtCreate":1637885432759,"gmtModify":1637885432759,"author":{"id":"3585598049271101","authorId":"3585598049271101","name":"Rachlim","avatar":"https://static.tigerbbs.com/f5fc898072e5f564ca0eac048de950ec","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Should buy?","listText":"Should buy?","text":"Should buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877393648","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6726234,"gmtCreate":1637885503864,"gmtModify":1637885503967,"authorId":3576844665898559,"author":{"id":3576844665898559,"authorId":3576844665898559,"name":"PrimRose","avatar":"https://static.tigerbbs.com/4749cd07ab1dd160b3c1f4da91927ff6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877393648,"type":1,"supId":0,"prevId":0,"content":"Go for it","text":"Go for it","html":"Go for it"}],"langContent":"CN"},{"id":877301614,"gmtCreate":1637884737488,"gmtModify":1637884742411,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0},"htmlText":"Yes, go for Modena. Buy and hodl for long!","listText":"Yes, go for Modena. Buy and hodl for long!","text":"Yes, go for Modena. Buy and hodl for long!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877301614","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":877303860,"gmtCreate":1637884608055,"gmtModify":1637893564953,"author":{"id":"4091758936365950","authorId":"4091758936365950","name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"For completeness, would also want the side effects and their severity reported. Possible to have the best of both worlds with any of these 5?","listText":"For completeness, would also want the side effects and their severity reported. Possible to have the best of both worlds with any of these 5?","text":"For completeness, would also want the side effects and their severity reported. Possible to have the best of both worlds with any of these 5?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/877303860","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6729872,"gmtCreate":1637901540532,"gmtModify":1637901540565,"authorId":4091758936365950,"author":{"id":4091758936365950,"authorId":4091758936365950,"name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3585001294737518,"repliedAuthor":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":877303860,"type":1,"supId":6727798,"prevId":6729299,"content":"[Happy]","text":"[Happy]","html":"[Happy]"},{"id":6729299,"gmtCreate":1637898023108,"gmtModify":1637898791282,"authorId":3585001294737518,"author":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4091758936365950,"repliedAuthor":{"id":4091758936365950,"authorId":4091758936365950,"name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":877303860,"type":1,"supId":6727798,"prevId":6728835,"content":"How I wonder if the smallpox vaccine creator can be still alive, maybe he will be able to create a 1 jab covid vaccine that will make us immune from covid virus and also without side effects too.","text":"How I wonder if the smallpox vaccine creator can be still alive, maybe he will be able to create a 1 jab covid vaccine that will make us immune from covid virus and also without side effects too.","html":"How I wonder if the smallpox vaccine creator can be still alive, maybe he will be able to create a 1 jab covid vaccine that will make us immune from covid virus and also without side effects too."},{"id":6728835,"gmtCreate":1637895178204,"gmtModify":1637895178300,"authorId":4091758936365950,"author":{"id":4091758936365950,"authorId":4091758936365950,"name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3585001294737518,"repliedAuthor":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":877303860,"type":1,"supId":6727798,"prevId":6728535,"content":"Seems so, with varying efficacy","text":"Seems so, with varying efficacy","html":"Seems so, with varying efficacy"},{"id":6728830,"gmtCreate":1637895160431,"gmtModify":1637895160460,"authorId":4091758936365950,"author":{"id":4091758936365950,"authorId":4091758936365950,"name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3585001294737518,"repliedAuthor":{"id":3585001294737518,"authorId":3585001294737518,"name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":877303860,"type":1,"supId":6727793,"prevId":6728182,"content":"[Sick]","text":"[Sick]","html":"[Sick]"},{"id":6728681,"gmtCreate":1637894380922,"gmtModify":1637894380952,"authorId":4091758936365950,"author":{"id":4091758936365950,"authorId":4091758936365950,"name":"MHh","avatar":"https://static.tigerbbs.com/54b2feced9ef5dcc9e95997d1f4db280","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877303860,"type":1,"supId":6728386,"prevId":0,"content":"Yes, that is the trade off. Hard to find a vaccine that is both efficacious and with not so serious side effects. Maybe novovax might fit the bill but not as widely used to tell","text":"Yes, that is the trade off. Hard to find a vaccine that is both efficacious and with not so serious side effects. Maybe novovax might fit the bill but not as widely used to tell","html":"Yes, that is the trade off. Hard to find a vaccine that is both efficacious and with not so serious side effects. Maybe novovax might fit the bill but not as widely used to tell"}],"langContent":"CN"},{"id":877975771,"gmtCreate":1637884342846,"gmtModify":1637884342846,"author":{"id":"3583060399914185","authorId":"3583060399914185","name":"Terc","avatar":"https://static.tigerbbs.com/030a47b34f2b276e172016715b3148e0","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877975771","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6725723,"gmtCreate":1637884348559,"gmtModify":1637884348583,"authorId":3583060399914185,"author":{"id":3583060399914185,"authorId":3583060399914185,"name":"Terc","avatar":"https://static.tigerbbs.com/030a47b34f2b276e172016715b3148e0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877975771,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":877975288,"gmtCreate":1637884324389,"gmtModify":1637884324528,"author":{"id":"3573432013960035","authorId":"3573432013960035","name":"Sphere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"MRNA is more superior&nbsp;","listText":"MRNA is more superior&nbsp;","text":"MRNA is more superior","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877975288","repostId":1178079040,"repostType":4,"repost":{"id":"1178079040","pubTimestamp":1637883095,"share":"https://www.laohu8.com/m/news/1178079040?lang=&edition=full","pubTime":"2021-11-26 07:31","market":"us","language":"en","title":"Moderna Edges Pfizer in Study of Five Covid Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178079040","media":"Bloomberg","summary":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioN","content":"<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.</p>\n<p>Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.</p>\n<p>The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.</p>\n<p>“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.</p>\n<p>Pfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.</p>\n<p>AstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.</p>\n<p>Both AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.</p>\n<p>Hungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Edges Pfizer in Study of Five Covid Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Edges Pfizer in Study of Five Covid Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-25/moderna-edges-pfizer-in-hungarian-study-of-five-covid-vaccines","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178079040","content_text":"TheModerna Inc.and Russian Sputnik V Covid-19 vaccines both edged the version fromPfizer Inc.andBioNTech SEin effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.\nModerna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against Covid-related mortality, compared with 85.7% and 95.4%, respectively for Sputnik, according to thepaperpublished Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.\nThe research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.\n“The wide range of vaccines available in Hungary allows for the assessment of vaccine effectiveness in a real-world setting in a Central European country and puts Hungary in the unique position of providing detailed information on multiple vaccine types from the same country,” the authors, including Hungary’s minister in charge of health-care, Miklos Kasler, and chief medical officer Cecilia Muller, wrote in the study.\nPfizer was administered most frequently, to 1.5 million people, followed by China’sSinopharmat 895,465, Russia’s Sputnik V at 820,560, AstraZeneca at 304,138 and Moderna at 222,892, according to the study. Pfizer and China’s Sinopharm had the highest share of vaccines administered to those aged 65 and over, while Sputnik had the lowest share, data showed.\nAstraZenecahad 71.5% effectiveness against infection and 74.5% against Covid-related death, while Sinopharm had 68.7% effectiveness against infection and 87.8% against death.\nBoth AstraZeneca and Sinopharm had less than 50% effectiveness against Covid infection in people aged 85 and older, according to the study. That compared with 90.9% for the same age group for Sputnik, 84.1% for Moderna and 74.3% for Pfizer.\nHungary had among the world’s highest Covid-related deaths per capita earlier this year. The country, whose vaccination rates lag the western European average, reported a record number of daily infections on Wednesday as the fourth wave of the virus continued to spread.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6725716,"gmtCreate":1637884329679,"gmtModify":1637884329756,"authorId":3573432013960035,"author":{"id":3573432013960035,"authorId":3573432013960035,"name":"Sphere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877975288,"type":1,"supId":0,"prevId":0,"content":"Up","text":"Up","html":"Up"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":104,"commentSize":13,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178079040"}